Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock par value $0.012 per share
-
Shares outstanding
-
41M
-
Number of holders
-
91
-
Total 13F shares, excl. options
-
5.41M
-
Shares change
-
+1.55M
-
Total reported value, excl. options
-
$119M
-
Value change
-
+$35.3M
-
Put/Call ratio
-
0.39
-
Number of buys
-
60
-
Number of sells
-
-22
-
Price
-
$21.98
Significant Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) as of Q3 2021
108 filings reported holding ORMP - ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share as of Q3 2021.
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) has 91 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.41M shares
of 41M outstanding shares and own 13.2% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.43M shares), Invesco Ltd. (755K shares), STATE STREET CORP (488K shares), GEODE CAPITAL MANAGEMENT, LLC (247K shares), NORTHERN TRUST CORP (226K shares), MORGAN JESS S & CO INC (214K shares), VANGUARD GROUP INC (160K shares), CALAMOS ADVISORS LLC (132K shares), Jetstream Capital LLC (120K shares), and MORGAN STANLEY (120K shares).
This table shows the top 91 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.